trial

Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis

NCTId NCT00484302
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 103 (actual)
Sponsored by Bispebjerg Hospital
Primary completion 2011-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
103 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2007-09
Primary completion
2011-01
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
Cognitive behavioral therapy with motivational interviewingNon-manualized standard treatment

Sponsors

Bispebjerg HospitalLead Sponsor
Copenhagen Trial Unit, Center for Clinical Intervention ResearchCollaborator
Sygekassernes HelsefondCollaborator
Københavns KommuneCollaborator
Lundbeck Canada Inc.Collaborator
Psychiatric Center CopenhagenCollaborator

Investigators

2
Merete Nordentoft, MD, PhD, MPHStudy Director
Merete Nordentoft, MD, PhD, MPHPrincipal Investigator

Sites

1 total
Copenhagen, Denmark

Facts & assertions

4 sourced
Enrollment
103
Phase
NA
Primary Completion Date
2011-01
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive behavioral therapy with motivational interviewing
drug
Non-manualized standard treatment
drug
lead_sponsor
Bispebjerg Hospital
company
collaborator
Copenhagen Trial Unit, Center for Clinical Intervention Research
company
Sygekassernes Helsefond
company
indication
Marijuana Abuse
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
investigator
Merete Nordentoft, MD, PhD, MPH
person
Merete Nordentoft, MD, PhD, MPH
person